Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study.
Morant R, Hsu Schmitz SF, Bernhard J, Thürlimann B, Borner M, Wernli M, Egli F, Forrer P, Streit A, Jacky E, Hanselmann S, Bauer J, Hering F, Schmid HP. Morant R, et al. Among authors: hering f. Eur J Cancer. 2002 Aug;38(12):1626-32. doi: 10.1016/s0959-8049(02)00145-4. Eur J Cancer. 2002. PMID: 12142053 Clinical Trial.
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, Switzerland.
Schmid HP, Maibach R, Bernhard J, Hering F, Hanselmann S, Gusset H, Morant R, Pestalozzi D, Castiglione M. Schmid HP, et al. Among authors: hering f. Cancer. 1997 May 1;79(9):1703-9. doi: 10.1002/(sici)1097-0142(19970501)79:9<1703::aid-cncr10>3.0.co;2-1. Cancer. 1997. PMID: 9128985 Clinical Trial.
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial.
Morant R, Bernhard J, Dietrich D, Gillessen S, Bonomo M, Borner M, Bauer J, Cerny T, Rochlitz C, Wernli M, Gschwend A, Hanselmann S, Hering F, Schmid HP. Morant R, et al. Among authors: hering f. Br J Cancer. 2004 Apr 5;90(7):1312-7. doi: 10.1038/sj.bjc.6601673. Br J Cancer. 2004. PMID: 15054447 Free PMC article. Clinical Trial.
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK).
Morant R, Bernhard J, Maibach R, Borner M, Fey MF, Thürlimann B, Jacky E, Trinkler F, Bauer J, Zulian G, Hanselmann S, Hürny C, Hering F. Morant R, et al. Among authors: hering f. Ann Oncol. 2000 Feb;11(2):183-8. doi: 10.1023/a:1008332724977. Ann Oncol. 2000. PMID: 10761753 Free article. Clinical Trial.
97 results